• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[口咽区肿瘤增殖活性指标作为放射治疗定性预后标准的应用]

[Use of the indicators of the proliferative activity of tumors of the oropharyngeal area as qualitative prognostic criteria of the radiotherapy].

作者信息

Poliakov P Iu, Karakulov R K, Pelevina I I, Zazovskiĭ L M, Dar'ialova S L

出版信息

Med Radiol (Mosk). 1986 Dec;31(12):25-9.

PMID:3796252
Abstract

Labeling index (LI) and growth fraction (GF) values were studied over time using biopsy specimens from patients with oropharyngeal cancer. The comparison of laboratory findings with tumor clinical response showed that a significant factor determining the tumor radiation reaction was the degree of LI and GF decrease during radiotherapy rather than their basal values. A favourable prognostic sign was a drop down to 0 or a sharp decrease in LI and GF values indicating a high tumor radiosensitivity, and enabling one to continue radiotherapy according to the radical program. A tumor could be considered radioresistant in case of an increase in LI and GF values by the end of an interval in the middle of a split course. In patients with resectable tumors treatment should end up with an operation; in those with unresectable tumors--it should be followed by combined radiotherapy, with an increased dose of interstitial gamma-therapy.

摘要

使用口咽癌患者的活检标本,对标记指数(LI)和生长分数(GF)值随时间进行了研究。实验室检查结果与肿瘤临床反应的比较表明,决定肿瘤放射反应的一个重要因素是放疗期间LI和GF下降的程度,而非其基础值。一个良好的预后迹象是LI和GF值降至0或急剧下降,这表明肿瘤具有高放射敏感性,并能使人们根据根治方案继续进行放疗。如果在分段疗程中间的一个间隔期结束时LI和GF值升高,则可认为肿瘤具有放射抗性。对于可切除肿瘤的患者,治疗应以手术结束;对于不可切除肿瘤的患者,应随后进行联合放疗,并增加间质γ治疗剂量。

相似文献

1
[Use of the indicators of the proliferative activity of tumors of the oropharyngeal area as qualitative prognostic criteria of the radiotherapy].[口咽区肿瘤增殖活性指标作为放射治疗定性预后标准的应用]
Med Radiol (Mosk). 1986 Dec;31(12):25-9.
2
[ORL brachytherapy. Focus on brachytherapy for squamous cell carcinoma of the oral cavity and pharynx].[口腔颌面部近距离放射治疗。聚焦于口腔和咽鳞状细胞癌的近距离放射治疗]
Bull Cancer Radiother. 1995;82(2):179-85.
3
[Prognostic factors and results of external irradiation of cancers of the base of the tongue].
Ann Otolaryngol Chir Cervicofac. 1985;102(7):519-24.
4
Analysis of prognostic factors in patients with oropharyngeal squamous cell carcinoma treated with radiotherapy alone or in combination with systemic chemotherapy.单纯放疗或联合全身化疗治疗口咽鳞状细胞癌患者的预后因素分析
Arch Otolaryngol Head Neck Surg. 2008 Nov;134(11):1196-204. doi: 10.1001/archotol.134.11.1196.
5
Nuclear DNA content, an adjunct to p53 and Ki-67 as a marker of resistance to radiation therapy in oral cavity and pharyngeal squamous cell carcinoma.核DNA含量,作为口腔和咽鳞状细胞癌放射治疗抗性标志物,是p53和Ki-67的辅助指标。
Int J Oral Maxillofac Surg. 2000 Feb;29(1):36-41.
6
[Radiotherapy of malignant tumors of the maxillofacial region].[颌面部恶性肿瘤的放射治疗]
Vestn Rentgenol Radiol. 1985 May-Jun(3):76-9.
7
Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume.口咽癌的调强放射治疗:肿瘤体积的影响
Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):43-50. doi: 10.1016/j.ijrobp.2003.08.004.
8
[Optimization of methods of radiotherapy of cancer of the tongue, mouth mucosa and oropharynx].[舌癌、口腔黏膜癌和口咽癌放射治疗方法的优化]
Med Radiol (Mosk). 1982 Aug;27(8):3-10.
9
Indications and results of combined external beam radiation and interstitial radiotherapy in the treatment of carcinoma of the oropharynx.口咽癌联合外照射放疗和组织间放疗的适应症及结果
Rays. 1991 Jan-Mar;16(1):97-106.
10
[Carcinoma of the oropharynx extended to the base of the tongue: radiosurgical treatment with intraoperative radiotherapy].[口咽癌累及舌根:术中放疗的放射外科治疗]
Bull Cancer Radiother. 1996;83(2):79-85.